Literature DB >> 6171916

Treatment of progressing stroke.

C H Millikan, F H McDowell.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6171916     DOI: 10.1161/01.str.12.4.397

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


× No keyword cloud information.
  8 in total

Review 1.  Perioperative stroke. Part I: General surgery, carotid artery disease, and carotid endarterectomy.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-04       Impact factor: 5.063

2.  Emergency carotid artery stent placement in patients with acute ischemic stroke.

Authors:  Keisuke Imai; Takahisa Mori; Hajime Izumoto; Masaki Watanabe; Kenichiro Majima
Journal:  AJNR Am J Neuroradiol       Date:  2005-05       Impact factor: 3.825

3.  Acute revascularization for progressing stroke.

Authors:  A Ogawa; T Yoshimoto; K Mizoi; T Sugawara; Y Sakurai; H Sato
Journal:  Acta Neurochir (Wien)       Date:  1991       Impact factor: 2.216

4.  Malignant ischemic stroke in the carotid district.

Authors:  G G Rebucci; G Ciucci; G Padoan
Journal:  Ital J Neurol Sci       Date:  1997-10

Review 5.  Carotid endarterectomy--when to do it, how to do it?

Authors:  H J Steiger
Journal:  Acta Neurochir (Wien)       Date:  1995       Impact factor: 2.216

6.  A clinical approach to cerebrovascular disease.

Authors:  J C Gautier; P Pullicino
Journal:  Neuroradiology       Date:  1985       Impact factor: 2.804

7.  The surgical management of vertebrobasilar insufficiency.

Authors:  R A de los Reyes; J I Ausman; F G Diaz; H Pak; J E Pearce; M Dujovny
Journal:  Acta Neurochir (Wien)       Date:  1983       Impact factor: 2.216

8.  The role of continuous-wave Doppler sonography in the diagnosis and management of basilar and vertebral artery occlusions, with special reference to its application during local fibrinolysis ("Vertebrobasilar disease. Time for a new strategy." Louis R. Caplan, 1981).

Authors:  E B Ringelstein; H Zeumer
Journal:  J Neurol       Date:  1982       Impact factor: 4.849

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.